Close Menu

NINDS

Under the terms of the five-year grant, Coriell will continue to support the NINDS Human Genetics Research Center.

In Genome Research this week: Sus scrofa genetic variants, translational plasticity might minimize effects of harmful mutations, and more.

Mutations in the PIEZO2 gene in two individuals with undiagnosed muscle, sensory, and skeletal conditions suggest the protein product plays a role in touch perception.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.

The grant from NINDS funds a gene expression analysis core for an existing project on type 1 regulatory T-cell development. 

The NIH has funded nine projects $5.9 million to investigate the biological and genetic etiology of sudden unexpected death in epilepsy

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will award $2.3 million next year for a study that will use imaging, omics, cognitive, and behavioral analysis to understand how chronic traumatic encephalopathy evolves in individuals.

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will support research projects to discover and use biomarkers for Parkinson's disease, NINDS said in a new funding announcement on Monday.

NEW YORK (GenomeWeb) – The National Institute of Health will award up to $3.4 million next year to fund genomics research programs and projects aimed at better understanding how two complex human genomic regions are involved in a range of immune system diseases.

NEW YORK (GenomeWeb News) – Using genome-wide RNAi screens, Richard Youle at the US National Institute of Neurological Disorders and Stroke and his colleagues have identified a bevy of regulators of

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.